Owners, management and financials
CVR: 44258048
DKK 129,466
Gross profit
Net result: DKK -588,453
Synamics Therapeutics Inc. (100%)
CVR · view owners
Violet Zahedi
Board: Aaron Daniel Capar (chair) and 3 members
CVR · view management
Active
Founded 24 August 2023
CVR · view overview
No headcount reported
Owner registered: Synamics Therapeutics Inc.
CVR · 27/03/2025
View the full event history
Synamics Therapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Violet Zahedi. The board consists of Aaron Daniel Capar (chair), Albert Jelke Kooistra, Per Falholt and Violet Zahedi. The company is owned by Synamics Therapeutics Inc.. In 2025, the company reported a gross profit of DKK 129,466 and a net result of DKK -588,453 compared with DKK -1,554,274 the year before. Equity in the 2025 report amounted to DKK -114,946.
Selskabets formål er at fremskynde opdagelsen af lægemidler gennem udvikling af kunstig intelligens og maskinlæring og at identificere nye forbindelser og mål
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 129 t. | -588 t. | 748 t. | -115 t. | - | |
| 202401/01/2024 – 31/12/2024 | -1.7 mio. | -1.6 mio. | 3.5 mio. | 473 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Synamics Therapeutics ApS is 44258048.
Synamics Therapeutics ApS is owned by Synamics Therapeutics Inc..
The management of Synamics Therapeutics ApS consists of Violet Zahedi.
The board of Synamics Therapeutics ApS consists of Aaron Daniel Capar, Albert Jelke Kooistra and Per Falholt, with Aaron Daniel Capar as chair.
In 2025, Synamics Therapeutics ApS reported a gross profit of DKK 129,466.
Synamics Therapeutics ApS was founded on 24 August 2023.
Claim this page to add your logo and social links. Free to get started.
Synamics Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK 129,466, and the net result was DKK -588,453.
Synamics Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -1,694,760, and the net result was DKK -1,554,274.
As of March 27, 2025, is registered as an owner of Synamics Therapeutics ApS with an ownership share of 100%.
As of July 9, 2024, Per Falholt has joined the board of directors of Synamics Therapeutics ApS.
As of July 9, 2024, Helder Takashi Imoto Nakaya has left the board of directors of Synamics Therapeutics ApS.
Synamics Therapeutics ApS has published its interim report for the period August 24, 2023 – December 31, 2023.
As of August 24, 2023, Violet Zahedi has joined the board of directors of Synamics Therapeutics ApS.
As of August 24, 2023, Aaron Daniel Capar has joined the board of directors of Synamics Therapeutics ApS.
As of August 24, 2023, Albert Jelke Kooistra has joined the board of directors of Synamics Therapeutics ApS.
As of August 24, 2023, Helder Takashi Imoto Nakaya has joined the board of directors of Synamics Therapeutics ApS.
As of August 24, 2023, Violet Zahedi is registered as director of Synamics Therapeutics ApS.
Synamics Therapeutics ApS was founded on August 24, 2023.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.


Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 26333210
CVR 26392861
CVR 41366044
CVR 27701396
CVR 33992890